Loading…

Biocomposites has entered into a multi-year agreement with Zimmer Biomet for exclusive distribution of the upgraded genex Bone Graft Substitute in the U.S. orthopaedic market. The product includes a new closed-mixing system and expanded delivery options.
“Biocomposites...announces that it has entered into a multi-year agreement with Zimmer Biomet...to exclusively distribute genex Bone Graft Substitute with its new mixing system and delivery options in the U.S. orthopaedic market.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.